Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women
- PMID: 38167144
- PMCID: PMC10763003
- DOI: 10.1186/s13058-023-01748-8
Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women
Abstract
Background: Previous work in European ancestry populations has shown that adding a polygenic risk score (PRS) to breast cancer risk prediction models based on epidemiologic factors results in better discriminatory performance as measured by the AUC (area under the curve). Following publication of the first PRS to perform well in women of African ancestry (AA-PRS), we conducted an external validation of the AA-PRS and then evaluated the addition of the AA-PRS to a risk calculator for incident breast cancer in Black women based on epidemiologic factors (BWHS model).
Methods: Data from the Black Women's Health Study, an ongoing prospective cohort study of 59,000 US Black women followed by biennial questionnaire since 1995, were used to calculate AUCs and 95% confidence intervals (CIs) for discriminatory accuracy of the BWHS model, the AA-PRS alone, and a new model that combined them. Analyses were based on data from 922 women with invasive breast cancer and 1844 age-matched controls.
Results: AUCs were 0.577 (95% CI 0.556-0.598) for the BWHS model and 0.584 (95% CI 0.563-0.605) for the AA-PRS. For a model that combined estimates from the questionnaire-based BWHS model with the PRS, the AUC increased to 0.623 (95% CI 0.603-0.644).
Conclusions: This combined model represents a step forward for personalized breast cancer preventive care for US Black women, as its performance metrics are similar to those from models in other populations. Use of this new model may mitigate exacerbation of breast cancer disparities if and when it becomes feasible to include a PRS in routine health care decision-making.
Keywords: African American; Breast cancer; Polygenic risk score; Risk prediction.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry.Breast Cancer Res Treat. 2018 Apr;168(3):703-712. doi: 10.1007/s10549-017-4638-1. Epub 2018 Jan 4. Breast Cancer Res Treat. 2018. PMID: 29302764 Free PMC article.
-
Prospective approach to breast cancer risk prediction in African American women: the black women's health study model.J Clin Oncol. 2015 Mar 20;33(9):1038-44. doi: 10.1200/JCO.2014.57.2750. Epub 2015 Jan 26. J Clin Oncol. 2015. PMID: 25624428 Free PMC article.
-
A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score.PLoS One. 2021 Jan 22;16(1):e0245375. doi: 10.1371/journal.pone.0245375. eCollection 2021. PLoS One. 2021. PMID: 33481864 Free PMC article.
-
Polygenic risk scores and breast cancer risk prediction.Breast. 2023 Feb;67:71-77. doi: 10.1016/j.breast.2023.01.003. Epub 2023 Jan 10. Breast. 2023. PMID: 36646003 Free PMC article. Review.
-
A Systematic Review and Critical Assessment of Breast Cancer Risk Prediction Tools Incorporating a Polygenic Risk Score for the General Population.Cancers (Basel). 2023 Nov 12;15(22):5380. doi: 10.3390/cancers15225380. Cancers (Basel). 2023. PMID: 38001640 Free PMC article. Review.
Cited by
-
Development and Validation of Dynamic 5-Year Breast Cancer Risk Model Using Repeated Mammograms.JCO Clin Cancer Inform. 2024 Dec;8:e2400200. doi: 10.1200/CCI-24-00200. Epub 2024 Dec 5. JCO Clin Cancer Inform. 2024. PMID: 39637342 Free PMC article.
-
Association between Apolipoprotein L1 genetic variants and risk of preeclampsia and preterm birth among U.S. Black women.Eur J Obstet Gynecol Reprod Biol X. 2025 Jan 9;25:100365. doi: 10.1016/j.eurox.2025.100365. eCollection 2025 Mar. Eur J Obstet Gynecol Reprod Biol X. 2025. PMID: 39895997 Free PMC article.
-
Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation.Diagnostics (Basel). 2024 Aug 21;14(16):1826. doi: 10.3390/diagnostics14161826. Diagnostics (Basel). 2024. PMID: 39202314 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical